Status:
COMPLETED
Heart Rate Variability in White Coat Hypertension and Essential Hypertension
Lead Sponsor:
Regional Hospital Holstebro
Conditions:
Essential Hypertension
White Coat Hypertension
Eligibility:
All Genders
30-70 years
Brief Summary
The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.
Eligibility Criteria
Inclusion
- age 30-70 years
- office BP \>150/95 mmHg and 24-h ambulatory BP =/\>135/85 mmHg
- office BP \>150/95 mmHg and 24-h ambulatory BP \<135/85 mmHg
- office BP \<150/95 mmHg and 24-h ambulatory BP \<135/85 mmHg
Exclusion
- Clinical signs of disease of the heart, lungs, liver, kidneys, brain or endocrine organs
- neoplastic disease
- daily use of medicine
- alcohol abuse
- abnormal laboratory screening including blood-hemoglobin, blood-white cell count, plasma-creatinine, plasma-alanine-amino-transaminases, plasma-albumin, plasma-sodium, plasma-potassium, urinary glucose, urinary albumin; electrocardiogram
- pregnancy
- unwillingness to participate
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT00286884
Last Update
September 11 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medical Research, Holstebro Hospital
Holstebro, Denmark, 7500